In the past decade, cancer medication development has shifted from a
In the past decade, cancer medication development has shifted from a concentrate on cytotoxic chemotherapies to medicines that focus on specific molecular alterations in tumors. primary among these methods. A remaining problem in both areas is definitely identifying medicines that get rid of drug-tolerant persister cells (infectious disease) or tumor-initiating/stem cells (malignancy) to avoid past … [Read more…]